Global Nanobiotechnology Market to Reach $160.3 Billion by 2030
The global market for Nanobiotechnology estimated at US$104.8 Billion in the year 2022, is projected to reach a revised size of US$160.3 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2022-2030. Pharmaceuticals & Biotechnology Industry, one of the segments analyzed in the report, is projected to record 6.3% CAGR and reach US$110.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Medical Devices segment is readjusted to a revised 3.9% CAGR for the next 8-year period.The U.S. Market is Estimated at $30.6 Billion, While China is Forecast to Grow at 4.8% CAGR
The Nanobiotechnology market in the U.S. is estimated at US$30.6 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$27.6 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.9% and 3.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.Select Competitors (Total 79 Featured) -
- Ablynx NV
- Arrowhead Pharmaceuticals Inc.
- CaPtivate Pharmaceuticals LLC
- Celgene Corporation
- ELITechGroup
- Flamel Technologies SA
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- NanoBio® Corporation
- Nanophase Technologies Corporation
- pSivida Corp.
- Sigma-Aldrich Corp.
- Starpharma Holdings Ltd.
- Vectura Group plc
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
CANADA
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
ITALY
UNITED KINGDOM
REST OF EUROPE
ASIA-PACIFIC
REST OF WORLD
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Ablynx NV
- Arrowhead Pharmaceuticals Inc.
- CaPtivate Pharmaceuticals LLC
- Celgene Corporation
- ELITechGroup
- Flamel Technologies SA
- GlaxoSmithKline Plc
- Johnson & Johnson
- Merck & Co. Inc.
- NanoBio® Corporation
- Nanophase Technologies Corporation
- pSivida Corp.
- Sigma-Aldrich Corp.
- Starpharma Holdings Ltd.
- Vectura Group plc
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 212 |
Published | March 2024 |
Forecast Period | 2020 - 2027 |
Estimated Market Value ( USD | $ 81.9 Billion |
Forecasted Market Value ( USD | $ 128.7 Billion |
Compound Annual Growth Rate | 6.7% |
Regions Covered | Global |